Profile data is unavailable for this security.
About the company
Jiangsu Recbio Technology Co Ltd is a China-based company mainly engaged in the research and development of vaccines. The Company has a portfolio of clinical-stage and pre-clinical stage vaccines, and its human papilloma virus (HPV) vaccine pipelines comprise of recombinant HPV 9-valent vaccine REC603, recombinant HPV 9-valent vaccines REC601 and REC602, recombinant HPV quadrivalent vaccine REC604a, and recombinant HPV 9-valent vaccine REC604b. The Company also involves in the development of Covid-19 vaccines. The Company mainly distributes products within domestic market.
- Revenue in HKD (TTM)0.00
- Net income in HKD-589.32m
- Incorporated2012
- Employees507.00
- LocationJiangsu Recbio Technology Co LtdNo. 888 Yaocheng AvenueChina Medical CityTAIZHOU ChinaCHN
- Phone+86 52 386818860
- Websitehttps://www.recbio.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Obio Technology Shanghai Corp Ltd | 270.54m | -265.09m | 3.94bn | 731.00 | -- | 1.96 | -- | 14.56 | -0.3834 | -0.3834 | 0.3915 | 2.89 | 0.1012 | 4.00 | 2.55 | 344,293.00 | -9.93 | 0.2246 | -11.17 | 0.2514 | -26.42 | 36.72 | -98.16 | 1.48 | 2.27 | -- | 0.104 | 0.00 | -29.69 | 35.88 | -425.90 | -- | 57.00 | -- |
| Pharming Group N.V. | 2.22bn | -138.71m | 3.96bn | 415.00 | -- | 2.27 | -- | 1.78 | -0.0266 | -0.0266 | 0.442 | 0.3171 | 0.663 | 0.524 | 6.44 | 656,132.50 | -4.14 | 5.26 | -4.99 | 6.63 | 89.39 | 89.41 | -6.24 | 9.26 | 2.76 | -4.84 | 0.3601 | -- | 19.30 | 9.01 | -177.14 | -- | -13.04 | -- |
| Zevra Therapeutics Inc | 192.89m | -660.92m | 3.98bn | 65.00 | -- | 7.24 | -- | 20.64 | -1.96 | -1.96 | 0.5825 | 1.31 | 0.150 | -- | 2.80 | 381,323.10 | -51.39 | -32.11 | -61.91 | -39.89 | 53.72 | -- | -342.63 | -128.42 | -- | -25.93 | 0.4578 | -- | 170.26 | -- | -72.00 | -- | 69.75 | -- |
| Emergent Biosolutions Inc | 8.76bn | -1.62bn | 4.00bn | 1.60k | -- | 1.05 | -- | 0.4564 | -4.10 | -4.10 | 21.19 | 9.40 | 0.6678 | 2.21 | 6.66 | 703,437.50 | -12.39 | -2.94 | -16.86 | -3.66 | 33.51 | 53.24 | -18.55 | -5.95 | 1.47 | -1.20 | 0.5658 | -- | -6.10 | 6.05 | -259.40 | -- | -4.29 | -- |
| Jiangsu Recbio Technology Co Ltd | 0.00 | -589.32m | 4.00bn | 507.00 | -- | 4.42 | -- | -- | -1.23 | -1.23 | 0.00 | 1.88 | 0.00 | -- | -- | 0.00 | -25.33 | -- | -32.84 | -- | -- | -- | -- | -- | 0.9619 | -- | 0.4548 | -- | -- | -- | 20.86 | -- | -- | -- |
| Solara Active Pharma Sciences Ltd | 1.13bn | -495.12m | 4.01bn | 2.16k | -- | 2.60 | -- | 3.55 | -137.13 | -137.13 | 320.29 | 301.63 | 0.4731 | 1.77 | 2.69 | 5,667,023.00 | -20.76 | -2.44 | -36.40 | -3.84 | 38.70 | 41.16 | -43.89 | -4.49 | 0.448 | -1.30 | 0.4355 | -- | -10.73 | -1.45 | -2,458.12 | -- | -4.81 | -- |
| Canopy Growth Corp | 1.56bn | -3.26bn | 4.01bn | 1.03k | -- | 1.07 | -- | 2.57 | -6.98 | -6.73 | 3.32 | 5.43 | 0.1934 | 2.17 | 6.16 | 272,590.90 | -40.38 | -26.08 | -48.35 | -28.67 | 31.47 | 2.59 | -208.81 | -333.29 | 1.07 | -0.2973 | 0.5462 | -- | -10.83 | 5.59 | 84.29 | -- | -64.60 | -- |
| Boiron SA | 3.93bn | 193.49m | 4.03bn | 2.79k | 20.37 | 1.29 | 11.64 | 1.02 | 1.36 | 1.36 | 27.74 | 21.48 | 0.7352 | 1.29 | 6.19 | 171,427.80 | 3.42 | 4.59 | 4.21 | 5.76 | 72.84 | 74.02 | 4.65 | 6.80 | 1.37 | -- | 0.0383 | 53.86 | -7.67 | -3.98 | -19.80 | -9.01 | -17.68 | -1.42 |
| Hunan Warrant Pharmaceutical Co Ltd | 1.55bn | 227.30m | 4.04bn | 1.16k | 17.76 | 2.00 | -- | 2.60 | 2.25 | 2.25 | 15.42 | 20.06 | 0.6426 | 1.49 | 9.74 | 1,244,707.00 | 8.34 | 11.21 | 9.79 | 14.05 | 61.32 | 69.00 | 12.98 | 13.96 | 3.18 | -- | 0.0566 | 8.05 | 10.84 | 18.50 | 15.60 | 19.02 | 24.49 | -- |
Data as of Nov 26 2024. Currency figures normalised to Jiangsu Recbio Technology Co Ltd's reporting currency: Hong Kong Dollar HKD
